Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder.

about

Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update "Salami Slicing" in Pooled Analyses of Second-Generation Antipsychotics for the Treatment of Depression.

P2860

Q28076712-4EB4276B-6361-4CE1-B74A-6B9A82200340 Q47890843-D5EC4014-1490-40E0-97BC-56EDD6D2F659

P2860

Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder.

Item

http://www.wikidata.org/entity/Q46532995

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Analysis of potentially predic ...... ith major depressive disorder.

@en

Analysis of potentially predic ...... ith major depressive disorder.

@nl

type

Item

label

Analysis of potentially predic ...... ith major depressive disorder.

@en

Analysis of potentially predic ...... ith major depressive disorder.

@nl

prefLabel

Analysis of potentially predic ...... ith major depressive disorder.

@en

Analysis of potentially predic ...... ith major depressive disorder.

@nl

P1476

Analysis of potentially predic ...... ith major depressive disorder.

@en

P2093

Hans Eriksson

http://www.w3.org/2001/XMLSchema#string

Michael Bauer

http://www.w3.org/2001/XMLSchema#string

Michael E Thase

http://www.w3.org/2001/XMLSchema#string

Sherry Liu

http://www.w3.org/2001/XMLSchema#string

Willie Earley

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for depression

No health without mental health

Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study

Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care.

Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.

Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial

Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis

Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms

P304

565-574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0269881114552715

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25257148

http://www.w3.org/2001/XMLSchema#string

Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder.

about

P2860

P2860

Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698